Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder
The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive disorder.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- University of Texas at Austin
- Principal investigator
- Gregory A Fonzo, Ph.D.
- Start date
- 2025-01-10
- End date
- 2030-12-31
- Registry ID
- NCT06132178
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.